TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted October 27, 1978
TCL Archive NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol July 25, 1997
TCL Archive In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle June 16, 1999
